Golimumab

Brand name: Simponi Aria

Rank #225 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$59.9M

Total Cost

Share:

8,718

Total Claims

$59.9M

Total Cost

471

Prescribers

$6,867

Cost per Claim

161

Beneficiaries

9,631

30-Day Fills

$127K

Avg Cost/Provider

19

Avg Claims/Provider

Share of Medicare Part D Spending

0.02%

of total Medicare Part D spending

$59.9M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $59.9M total

🔎 Data Overview

💰

At $6,867 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $127,114 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

👤

Average cost of $371,868 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Golimumab

#ProviderSpecialtyLocationClaimsCost
1Gerald HoRheumatologyLa Palma, CA119$852K
2James GoreRheumatologyNashville, TN92$753K
3Guillermo ValenzuelaRheumatologyPlantation, FL71$565K
4Swati ShahRheumatologyJacksonville, FL66$539K
5Jacqueline VoRheumatologyHouston, TX58$470K
6Ricardo Garcia AlemanyRheumatologyHialeah, FL54$426K
7Gregory RihacekInternal MedicineSomerset, NJ66$384K
8Ronald GeorgeRheumatologyWilmington, NC60$377K
9Edmund LacourRheumatologyDothan, AL49$363K
10Luisana GomezPhysician AssistantMonterey Park, CA61$362K
11Dennis SuarezRheumatologyMayaguez, PR60$360K
12Anne Marie HollyPhysician AssistantRochester, NY54$343K
13Marcy BauerNurse PractitionerBoise, ID45$331K
14Barry EibschutzRheumatologySan Luis Obispo, CA36$329K
15Olga KromoRheumatologySouth Miami, FL42$326K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology